Jo Ann K LeQuang
Overview
Explore the profile of Jo Ann K LeQuang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pergolizzi J, LeQuang J
Cureus
. 2024 Oct;
16(9):e69346.
PMID: 39398691
Expert testimony can play a pivotal role in a legal case involving a medical issue, but it is crucial that this testimony be scientifically sound. In the United States, the...
2.
Pergolizzi J, LeQuang J, El-Tallawy S, Ahmed R, Wagner M, Varrassi G
Cureus
. 2024 Jul;
16(6):e61898.
PMID: 38978896
The lack of established laboratory tests or biomarkers for trigeminal neuralgia (TN) makes diagnosing this relatively rare condition extremely challenging. Trigeminal nerve compression observable on magnetic resonance imaging may indicate...
3.
Pergolizzi Jr J, LeQuang J, Wagner M, Varrassi G
Cureus
. 2024 Jun;
16(5):e60698.
PMID: 38899235
In "graying" populations with extended lifespans and survivable forms of cancer, palliative services become increasingly important but may be difficult to introduce into public discourse, public policy, and healthcare systems....
4.
Pergolizzi Jr J, LeQuang J, Wagner M, Salah R, Magnusson P, Varrassi G
Cureus
. 2024 Jun;
16(5):e59587.
PMID: 38826984
As estrogen-dependent breast cancer is more affected by the local production of estrogen via aromatase than serum estrogen, aromatase inhibitors for treating breast carcinomas in postmenopausal women have been developed....
5.
Tabor A, LeQuang J, Pergolizzi Jr J
Cureus
. 2024 Apr;
16(3):e55499.
PMID: 38571870
The heritable condition epidermolysis bullosa (EB) is a rare but potentially devastating and life-threatening condition that is characterized primarily by cutaneous fragility, manifested when the dermis and epidermis fail to...
6.
Pergolizzi Jr J, LeQuang J, Vortsman E, Magnusson P, El-Tallawy S, Wagner M, et al.
Cureus
. 2024 Mar;
16(2):e55053.
PMID: 38550445
First developed in the 1960s in Europe and approved briefly for use in the United States, fenethylline (sold as Captagon, one of its early trade names) is now a prominent...
7.
Tabor A, LeQuang J, Pergolizzi Jr J
Cureus
. 2024 Mar;
16(2):e53774.
PMID: 38465068
Epidermolysis bullosa (EB) is a rare genetic condition characterized by fragile skin caused by impaired adhesion between the dermis and epidermis. EB is present at or near birth. There is...
8.
Pergolizzi Jr J, Matera J, LeQuang J
Cureus
. 2024 Jan;
15(12):e49909.
PMID: 38174176
The sudden and enormous popularity of pickleball has included a surprising and large contingent of geriatric players. Similar to tennis and badminton, pickleball is a game with a short learning...
9.
El-Tallawy S, Ahmed R, Shabi S, Al-Zabidi F, Zaidi A, Varrassi G, et al.
Cureus
. 2024 Jan;
15(11):e49639.
PMID: 38161929
Pain in dementia patients is common, poorly measured, and undertreated. It is important to discuss the challenges in the pain assessment and management to find a possible solution for adequate...
10.
Pergolizzi Jr J, Pergolizzi C, LeQuang J
Cureus
. 2023 Nov;
15(10):e47819.
PMID: 38022306
With the burgeoning numbers of clinical trials, the competition among sponsors for research subjects has grown intensely. Many clinical trials fail to meet their recruitment goals. Contract research organizations (CROs)...